Vyntus® WALK Wirelessly Assesses Functional Exercise Capacity

SAN DIEGO, Sept. 16, 2015 - CareFusion, a BD company (NYSE: BDX), announces the availability of a new respiratory diagnostics tool that is a complete mobile solution for assessing functional exercise capacity in patients.

Vyntus® WALK allows clinicians to conduct the 6-minute walk test (6MWT) fully independent of any external wires or means of connection. The application seamlessly integrates with CareFusion's Windows-based SentrySuite diagnostic platform and software to enable further evaluation, central data management and reporting, but it also functions in standalone mode, independent of a proprietary database interface. In the latter case, reports can be printed directly from the tablet, scanned into the electronic medical record (EMR) or printed to a network PDF location.

"The Vyntus WALK has received positive reviews from patients in Europe, where the technology is already in use," said Dan Woolson, worldwide president Respiratory Solutions for BD. "In addition, the application is workflow driven, and provides the clinician onscreen guidance to assist the patient during the test for the best possible results."

A recommended protocol of the American Thoracic Society because it mirrors the levels of exertion typical of daily living, the 6MWT is conducted using Vyntus WALK with the patient wearing wireless sensors that communicate heart rate and SpO2 values from a wrist pulse oximeter to a tablet PC.

The clinician can also manually enter related data such as blood pressure, oxygen supply, oxygen supply type, rate of perceived exertion and BODE index.

About CareFusion

CareFusion, a BD company, serves the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. For more information please visit www.carefusion.com.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving medication management and patient safety; supporting infection prevention practices; equipping surgical and interventional procedures; improving drug delivery; aiding anesthesiology and respiratory care; advancing cellular research and applications; enhancing the diagnosis of infectious diseases and cancers; and supporting the management of diabetes. We are more than 45,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. In 2015, BD welcomed CareFusion and its products into the BD family of solutions. For more information on BD, please visit www.bd.com.

# # #

For further information: Media: Troy Kirkpatrick, (858) 617-2361, troy.kirkpatrick@carefusion.com ; Investors: Monique N. Dolecki, (201) 847-5453, monique_dolecki@bd.com

distributed by